FAIRFIELD, N.J.--(BUSINESS WIRE)--Warren P. Levy, Ph.D., CEO and President of Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com), a biopharmaceutical company focusing on the manufacturing and oral delivery of large-market peptide drugs, recently contributed a by-lined story in two leading pharmaceutical publications. The article, which highlights the importance of peptides in pharmaceutical research as well as the potential value of the company’s proprietary technologies, appeared in Genetic Engineering & Biotechnology News (GEN), the most widely read biotechnology publication in the world, and Pharmaceutical Formulation & Quality Magazine (PFQ), a health care journal with national circulation .
